Document is current
Any future updates will be listed below
-
Authors
Salle, Laurence
Julla, Jean-Baptiste
Fagherazzi, Guy
Gourdy, Pierre
Bezerra Parente, Erika
Hanaire, Hélène
Tatulashvili, Sopio
Disse, Emmanuel
Franc, Sylvia
Hadjadj, Samy
Larger, Etienne
Sanz, Caroline
Vaduva, Patricia
Valero, René
Bonnefond, Amélie
Cosson, Emmanuel
Aguayo, Gloria A.
Riveline, Jean-Pierre
,
- License Information
-
More Information
Article History
Received: 14 March 2025
Accepted: 13 May 2025
First Online: 14 June 2025
Declarations
:
: SFDT1 was approved by an ethical committee on 5 November 2019 and is declared in clinical trial NCT04657783.
: Not applicable.
: EBP reports receiving lecture honorariums from Astra Zeneca and Sanofi, and has been an employee of Boehringer Ingelheim since February 2024. The other authors declare that they have no competing interests.
